FDA/CDC
FDA/CDC
FDA allows marketing of TMS to treat OCD
Transcranial magnetic stimulation already is approved to treat refractory major depression and migraine with aura.
FDA/CDC
CDC: 2017 worst year yet for drug overdoses
Deaths tied to synthetic opioids climbed faster than any other drug class.
FDA/CDC
FDA proposes broader outcomes for OUD treatment drug approvals
Draft guidance supports various clinical endpoints, including changes in drug use patterns other than the endpoint of abstinence.
FDA/CDC
FDA approves Perseris for schizophrenia
The drug achieved clinically relevant levels without the need for a loading or supplemental doses.
FDA/CDC
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
FDA/CDC
Cost led to missed care for 4.5% of Americans in 2017
Steady decline in national rate appears to have halted.
FDA/CDC
Obesity didn’t just happen overnight
Data seem to suggest that exercise makes Americans gain weight.
FDA/CDC
Generic versions of Suboxone approved for opioid dependence
The FDA says patients who receive medication-assisted treatment for opioid use disorder reduce their risk of death from all causes by 50%.
FDA/CDC
CDC warns of hepatitis A outbreaks in injection drug users
Gap in vaccine availability now has been solved.
FDA/CDC
Suicides up 30%; risk factors go beyond diagnosed disorders
FDA/CDC
FDA effort focuses on approving more generic drugs
Changes to how REMS are written for generic drugs could bring more to market.